The fund will be managed by the Life Sciences Corporate Venture Capital (LS-CVC), a newly established group within Fujifilm’s Life Sciences Strategy Headquarters in Tokyo. The group will also take on the management of Fujifilm’s existing life science investment portfolio: which includes investments in regenerative medicine, cell therapeutics and drug discovery research products.
For Fujifilm, the new fund will allow it to ‘cultivate and foster relationships with emerging biotechs to create new and strengthen existing businesses’.
Unmet medical needs
In April 2021, Fujifilm established the Life Sciences Strategy Headquarters to plan and promote a comprehensive, integrated strategy to accelerate business growth in the life sciences field.
This headquarters manages several business divisions within the fields of biopharmaceutical contract development and manufacturing, iPS cell-derived products for drug and discovery research markets, and industrial cell culture media.
In the new strategic investment fund, it will be responsible for the placement of funding, while life science offices in Cambridge in the US and Dusseldorf in Europe will be involved in approaching early-stage biotechs and drawing up deals.
“In the field of life sciences, research and development of new technologies and application of biotechnologies have been accelerated to deliver solutions for unmet medical needs and other societal issues, such as food and environmental problems,” said Takatoshi Ishikawa, General Manager of Life Sciences Strategy Headquarters.
"impact" - Google News
February 14, 2022 at 09:37PM
https://ift.tt/pRHsuEZ
Fujifilm launches strategic investment fund for high impact biotech - BioPharma-Reporter.com
"impact" - Google News
https://ift.tt/8Jgzxos
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Fujifilm launches strategic investment fund for high impact biotech - BioPharma-Reporter.com"
Post a Comment